Case Study

How AstraZeneca Improved Validated Workflows In GMP API Manufacturing

Source: Dassault Systèmes BIOVIA
How AstraZeneca Improved Validated Workflows In GMP API Manufacturing

The reality is that paper is more of a habit than a requirement. AstraZeneca discovered this when they aimed to introduce ELNs to improve the efficiency of their validated workflows for GMP API (active pharmaceutical ingredient) manufacture. Paper and its associated workflows were standard only because they were familiar and had been defined over time to meet the needs of scientists, process engineers and quality control and assurance staffs.